When the Apple Watch was paired with a machine-learning algorithm, it could accurately spot irregular heartbeats, according to a new study.
The CMS will now cover diagnostic laboratory tests using gene sequencing technology for Medicare cancer patients. The agency said the tests can help patients and their oncologists make better treatment decisions.
Though healthcare organizations are spending more on IT, they're suffering more cyberattacks too. Surveyed organizations experienced an average of 16 cyberattacks each in 2017.
The CMS has called off its plan to hasten Medicare coverage for devices. Industry stakeholders say the canceled initiative is a missed opportunity to get seniors the devices they need.
Medical devices that are connected to hospital computer systems create vulnerabilities that can be difficult to manage.
Hill-Rom CEO John Greisch is betting there's more money to be made in blood pressure monitors and retina-scanning devices than adjustable hospital mattresses.
The J.P. Morgan Healthcare Conference in San Francisco concluded Thursday with Castlight Health's announcement that the price transparency company expects to break even by the end of 2018 following years of losses, among other presentations.
Medicare Part D plans now cover more innovative insulin-delivering products following a bipartisan push from members of Congress to expand that coverage. Some seniors had been delaying retirement or facing thousands of dollars in out-of-pocket costs prior to the policy change.
The squiggly fish's electrical capacity possesses characteristics that researchers say could perhaps be applied to power medical devices, leading to power sources that could have an edge over traditional batteries.
While much of corporate America will enjoy a tax cut in the new year, medical-device manufacturers are getting a tax increase they have fought hard, yet unsuccessfully so far, to avoid.
Nearly nine years after a consortium of hospitals first started planning to bring a proton-beam therapy center to New York City, the more than $300 million project is nearing completion.
San Diego's only cancer-targeting proton treatment center has leveraged an infusion of capital and new leadership to relaunch as California Protons following Chapter 11 bankruptcy.